Patent Ductus Arteriosus Closure by Paracetamol in a Critical Preterm Infant after Late Recanalization

Main Article Content

Abdelmonem Helal
Naif Alkhushi
M. O. Galal

Abstract

Cyclooxygenase (COX) inhibitors form the first line of treatment for patent ductus arteriosus (PDA) in preterm neonates. However, their efficacy decreases with increasing postnatal age. Paracetamol can be used when COX inhibitors are contraindicated and in advanced postnatal age. We describe a late preterm neonate (five weeks postnatal age, 1550 g birth weight) with a hemodynamically significant PDA, where COX inhibitor therapy could not be initiated due to spontaneously perforated necrotizing enterocolitis that was treated surgically. At five weeks postnatal age and body weight of 1800 g intravenous paracetamol was started. Over a 3-day course, it led to complete closure of the PDA. With follow up three months after treatment, recanalization occurred but did not need further attention.

Keywords:
Paracetamol, Patent Ductus Arteriosus (PDA), necrotizing enterocolitis, preterm infant

Article Details

How to Cite
Helal, A., Alkhushi, N., & Galal, M. O. (2020). Patent Ductus Arteriosus Closure by Paracetamol in a Critical Preterm Infant after Late Recanalization. Asian Journal of Research in Cardiovascular Diseases, 2(3), 22-26. Retrieved from https://journalijrrc.com/index.php/AJRCD/article/view/30109
Section
Case Report

References

Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev. 2015;2:CD003481.

Achanti B, Yeh TF, Pildes RS. Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus. Clin Invest Med. 1986;9:250-3.

Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: Pathophysiology and management. J Perinatol. 2006; 26(Suppl 1):S22-3.

Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants. Cochrane Database Syst Rev. 2015;3:CD010061.

Roofthooft DW, van Beynum IM, de Klerk JC, van Dijk M, van den Anker JN, Reiss IK, et al. Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure. Eur J Pediatr. 2015;174: 1433-40.

EL-Khuffash A, James AT, Cleary A, Semberova J, Franklin O, Miletin J. Late medical therapy of patent ductus arteriosus using intravenous paracetamol. Arch Dis Child Fetal Neonatal Ed. 2015;100(3): F253-6.

DOI: 10.1136/archdischild-2014-307930

Epub 2015 Feb 4. PubMed PMID: 25653299

Tan Z. H., Baral V. R. Principles of clinical management of patent ductus arteriosus in extremely preterm neonates. Current Pediatric Reviews. 2016;12(2):83–97.

DOI:10.2174/157339631202160506001309

Bauer AZ, Kriebel D. Prenatal and perinatal analgesic exposure and autism: An ecological link. Environ Health. 2013; 12:41.

DOI: 10.1186/1476-069X-12-41

EL-Khuffash A, James AT, Cleary A. Late medical therapy of patent ductus arteriosus using intravenous paracetamol. Archives of Disease in Childhood - Fetal and Neonatal Edition. 2015;100:F253-F256.

Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: A randomized controlled trial. PLoS One. 2013;8(11): e77888.

DOI: 10.1371/journal.pone.0077888

eCollection 2013. PubMed PMID: 24223740; PubMed Central PMCID: PMC3817181